Long run is <b> ONCS ! </b> even though BB stock worth a buy IMHO. Radio interview with Punit Dhillon, the CEO and co-founder of OncoSec: http://www.wallstreetreporter.com/2012/09/oncosec-medical-otcqboncs-ceo-interview/ A few of the major points: 1.) Evaluating a global partnership 2.) China is a large opportunity; also evaluating India, other Asian countries, and Europe. 3.) They are continuing to demonstrate for investors, some of which have been quite impressed. 4.) He discusses the milestones that ONCS has hit and those to be hit in the future. 5.) ONCS is still under many investors' radars. 6.) ONCS is a stock for the long run.